The GCI Dashboard

Version:
Share: whatsapp
Country Rank

137


United States

Recovery Rank for 180 countries/regions

Country Rank

53


United States

Recovery Rank for 184 countries/regions

COVID-19 Recovery Rating

3

Recovery Index
51.66
(Out of 100)



(100 = Best, 0 = Worst)

COVID-19 Recovery Rating

4

Recovery Index
61.00
(Out of 100)



(100 = Best, 0 = Worst)

COVID-19 Severity Rating

4

Severity Index
56.54
(Out of 100)



(0 = Best, 100 = Worst)

COVID-19 Severity Rating

2

Severity Index
44.52
(Out of 100)



(0 = Best, 100 = Worst)

Stringency Rating

69.57

(100 = Strictest Measures, 0 = No Measures)


Population
328,239,523

(Medium Density)


GNI per capita (US$)

63,170

(High income)
5 Countries who have made the most progress in
curtailing the spread of the pandemic and can be
used as examples of best practices (Relative Rating)

4
3
2 Countries who are struggling to cope with the crisis
and who may need to consider maintaining stringent
non-pharmaceutical measures (Relative Rating)
1
1 Countries who are coping with the crisis with a low percentage
of infections and resulting deaths per population
(Relative Rating)
2
3 Countries who may be overwhelmed by the crisis with a high
percentage of infections and resulting deaths per population
(Relative Rating)
4
5

Travel Advisory


1. Passengers entering or transiting through the USA must have a COVID-19 vaccination certificate showing that they were fully vaccinated at least 15 days (day of vaccination + 14
days) before arrival. Passenger details (e.g., name and date of birth) in the certificate must match those stated in the passport/travel document. Vaccines accepted are: -
AstraZeneca (SK Bioscience), AstraZeneca (Vaxzevria), Covishield, Covaxin, Janssen, Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm and Sinovac. A combination of these
vaccines is accepted if administered at least 17 days apart. More details can be found at www.cdc.gov/coronavirus/2019-ncov/travelers/international-travel-during-covid19.html This
does not apply to: - nationals of the USA - residents of the USA; - passengers younger than 18; - passengers with a letter issued by a doctor proving that the passenger is
medically unable to receive the vaccine; - passengers with the following visas: A-1, A-2, C-2, C-3 (as a foreign government official or immediate family member of an official), E-1
(as an employee of TECRO or TECO or the employee's immediate family members), G-1, G-2, G-3, G-4, NATO-1 through NATO-4, or NATO-6 (or seeking to enter as a nonimmigrant in one of
those NATO classifications); - passengers with a letter of invitation or other official document, issued by the USA, by other government or by the United Nations, traveling on
duty; - nationals of Afghanistan, Algeria, Angola, Armenia, Benin, Burkina Faso, Burundi, Cameroon, Central African Rep., Chad, Congo, Congo (Dem. Rep.), Cote d'Ivoire, Djibouti,
Egypt, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Haiti, Iraq, Kenya, Kiribati, Liberia, Libya, Madagascar, Malawi, Mali, Mozambique, Myanmar, Namibia, Nicaragua,
Niger, Nigeria, Papua New Guinea, Senegal, Sierra Leone, Solomon Isl., Somalia, South Sudan, Syria, Tanzania, Togo, Uganda, Vanuatu, Yemen and Zambia, with a visa issued by the
USA, excluding B -1 and B -2 visas; - members of the U.S. Armed Forces, their spouses, and children younger than 18 years; - merchant seamen with one of the following visas: C, D,
C1/D, B1, H or L. - More details can be found at Requirement for Proof of COVID-19 Vaccination for Air Passengers | CDC

2. Passengers entering or transiting through the USA must have a negative COVID-19 test taken at most 1 day before departure from the first embarkation point. Tests accepted are:
antigen, NAAT, RT-LAMP, RT-PCR or TMA. - This does not apply to: - passengers younger than 2 years; - passengers with a positive COVID-19 test taken at most 90 days before
departure from the first embarkation point; and - a letter issued by a health authority stating that the passenger has been cleared for travel.

3. Passengers must complete an attestation form before departure. The form can be found at https://tinyurl.com/f39bu7dt - This does not apply to passengers younger than 2 years.

4. Passengers are subject to COVID-19 measures set by the state/territory of their final destination. More information can be found at
www.cdc.gov/publichealthgateway/healthdirectories/healthdepartments.html

5. DV visas issued in September 2020 that expired are accepted for entry.

6. Nationals of the U.S.A. are allowed to enter with an expired passport. -This does not apply to emergency passports which must be valid on arrival.

7. Passengers could be subject to self-isolation or self-quarantine. - This does not apply to: - passengers with a COVID-19 recovery certificate proving recovery in the past 90
days; - passengers with a COVID-19 vaccination certificate showing that they were fully vaccinated at least 15 days (day of vaccination + 14 days) before arrival. Passenger details
(e.g., name and date of birth) in the certificate must match those stated in the passport/travel document. Vaccines accepted are: - AstraZeneca (SK Bioscience), AstraZeneca
(Vaxzevria), Covishield, Covaxin, Janssen, Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm and Sinovac. A combination of these vaccines is accepted if administered at
least 17 days apart. More details can be found at www.cdc.gov/coronavirus/2019-ncov/travelers/international-travel-during-covid19.html

Travel Advisory information provided and published with permission by IATA. (Timatic COVID-19 Alerts Service has been discontinued on 1/1/2022, please refer this page for latest travel advisory)


United States Infection Trend


How can you tell if a curve is really flattening?

The number of daily confirmed cases has been used as an estimation of how severe the COVID-19 situation is in a given country. However, we’ve found that focusing on the country’s cumulative number of active cases gives a clearer picture of whether the infection curve is flattening.


Countries with Similar Characteristics


This table is generated by a GCI-developed tool to match countries based on their similar characteristics such as population, population density, income and climate.

United States 61.00 51.66 328,239,523 Medium Density High income < 10 deg
Country Recovery Index Recovery Index Population Density GNI per capita Average Temperature
since First Case (Celsius)
Match%
China 71.88 80.28 1,397,715,000 Medium Density Upper middle income < 10 deg 75%
Ethiopia 52.54 58.14 112,078,730 Medium Density Low income 26-30 deg 60%
Indonesia 69.12 72.43 270,625,568 Medium Density Upper middle income 26-30 deg 60%
Mexico 54.65 59.11 127,575,529 Medium Density Upper middle income 21-25 deg 60%
Nigeria 53.56 63.29 200,963,599 Medium Density Lower middle income 26-30 deg 60%

GCI Recovery Forecast


The GCI Recovery Forecasting methodology relies on a Monte Carlo simulation model as we recognise that the factors that contribute to an increase / decrease in confirmed COVID19 cases are highly variable and subject to various localised circumstances and interventions. The P10 / P50 / P90 are probabilities assigned to the forecasts, with P10 being highly optimistic, and P90 being very conservative on recovery and reduction in cases. The forecast model is updated daily based on the latest case data.

Forecast Results:

Situation Worsening. Infections are forecasted to continue to be on the rise. Interventions are required, if not already in place.




Reviewed and Endorsed by:

In Collaboration and
Partnership with:

image

Recognition and Award:

Chairman's Award



Key Sponsor: